Androgen receptor signaling pathways as a target for breast cancer treatment
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Androgen receptor signaling pathways as a target for breast cancer treatment
Authors
Keywords
-
Journal
ENDOCRINE-RELATED CANCER
Volume 23, Issue 10, Pages R485-R498
Publisher
Bioscientifica
Online
2016-08-16
DOI
10.1530/erc-16-0190
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer
- (2016) Erik Hilborn et al. BRITISH JOURNAL OF CANCER
- Clinical verification of sensitivity to preoperative chemotherapy in cases of androgen receptor-expressing positive breast cancer
- (2016) Yuka Asano et al. BRITISH JOURNAL OF CANCER
- Abstract P6-07-08: Androgen receptor (AR) mutations in a cohort of patients with breast cancer (BC) who have undergone tumor genomic profiling
- (2016) A Gucalp et al. CANCER RESEARCH
- Complete Response of Metastatic Androgen Receptor–Positive Breast Cancer to Bicalutamide: Case Report and Review of the Literature
- (2016) Claudia Arce-Salinas et al. JOURNAL OF CLINICAL ONCOLOGY
- Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer
- (2015) J. O'Shaughnessy et al. ANNALS OF ONCOLOGY
- Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone
- (2015) S Salvi et al. BRITISH JOURNAL OF CANCER
- The polymorphism of CAG repeats in the androgen receptor gene and breast cancer mortality
- (2015) Yu-Ting Lee et al. Cancer Biomarkers
- Abstract P1-13-04: Enobosarm for the treatment of metastatic, estrogen and androgen receptor positive, breast cancer. Final results of the primary endpoint and current progression free survival
- (2015) Beth Overmoyer et al. CANCER RESEARCH
- Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer
- (2015) A. A. Azad et al. CLINICAL CANCER RESEARCH
- Targeting the androgen receptor in prostate and breast cancer: several new agents in development
- (2015) T. Proverbs-Singh et al. ENDOCRINE-RELATED CANCER
- Coagulation factor VII is regulated by androgen receptor in breast cancer
- (2015) Ali Naderi EXPERIMENTAL CELL RESEARCH
- Influence of Androgen Receptor Expression on the Survival Outcomes in Breast Cancer: A Meta-Analysis
- (2015) Yoonseok Kim et al. Journal of Breast Cancer
- Response
- (2015) Alberto Ocana et al. JNCI-Journal of the National Cancer Institute
- RE: Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis
- (2015) Yadong Wang et al. JNCI-Journal of the National Cancer Institute
- Testosterone and breast cancer prevention
- (2015) R. Glaser et al. MATURITAS
- Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide In Vivo
- (2015) V. N. Barton et al. MOLECULAR CANCER THERAPEUTICS
- Impact of Candidate Genetic Polymorphisms in Prostate Cancer: An Overview
- (2015) S. Salvi et al. Molecular Diagnosis & Therapy
- Targeting the glucocorticoid receptor in breast and prostate cancers
- (2015) Jacob Kach et al. Science Translational Medicine
- Plasma AR and abiraterone-resistant prostate cancer
- (2015) Alessandro Romanel et al. Science Translational Medicine
- CAG repeat polymorphisms in the androgen receptor and breast cancer risk in women: a meta-analysis of 17 studies
- (2015) Qixing Mao et al. OncoTargets and Therapy
- Targeting the Androgen Receptor in Breast Cancer
- (2015) KeeMing Chia et al. Current Oncology Reports
- Response
- (2015) Alberto Ocana et al. JNCI-Journal of the National Cancer Institute
- RE: Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis
- (2015) Yadong Wang et al. JNCI-Journal of the National Cancer Institute
- A Feedback Loop between Androgen Receptor and ERK Signaling in Estrogen Receptor-Negative Breast Cancer
- (2015) Kee Ming Chia et al. NEOPLASIA
- Androgen Receptor Expression Predicts Decreased Survival in Early Stage Triple-Negative Breast Cancer
- (2014) Jung Eun Choi et al. ANNALS OF SURGICAL ONCOLOGY
- Androgen receptor phosphorylation: biological context and functional consequences
- (2014) Yulia Koryakina et al. ENDOCRINE-RELATED CANCER
- Revising the role of the androgen receptor in breast cancer
- (2014) F M Fioretti et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor clone dynamics in lethal prostate cancer
- (2014) S. Carreira et al. Science Translational Medicine
- Selective androgen receptor modulators as improved androgen therapy for advanced breast cancer
- (2014) Christopher C. Coss et al. STEROIDS
- Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
- (2013) H. Masuda et al. CLINICAL CANCER RESEARCH
- Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
- (2013) A. Gucalp et al. CLINICAL CANCER RESEARCH
- Amplitude modulation of androgen signaling by c-MYC
- (2013) M. Ni et al. GENES & DEVELOPMENT
- Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis
- (2013) F. E. Vera-Badillo et al. JNCI-Journal of the National Cancer Institute
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
- (2013) Muhammed Murtaza et al. NATURE
- Liquid biopsy: monitoring cancer-genetics in the blood
- (2013) Emily Crowley et al. Nature Reviews Clinical Oncology
- The Impact of Androgen Receptor Expression on Breast Cancer Survival: A Retrospective Study and Meta-Analysis
- (2013) Qing Qu et al. PLoS One
- An F876L Mutation in Androgen Receptor Confers Genetic and Phenotypic Resistance to MDV3100 (Enzalutamide)
- (2013) M. Korpal et al. Cancer Discovery
- A Clinically Relevant Androgen Receptor Mutation Confers Resistance to Second-Generation Antiandrogens Enzalutamide and ARN-509
- (2013) J. D. Joseph et al. Cancer Discovery
- Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC)
- (2012) Che-Kai Tsao et al. BJU INTERNATIONAL
- Higher expression of androgen receptor is a significant predictor for better endocrine-responsiveness in estrogen receptor-positive breast cancers
- (2012) Seho Park et al. BREAST CANCER RESEARCH AND TREATMENT
- Allosteric Modulators of Steroid Hormone Receptors: Structural Dynamics and Gene Regulation
- (2012) Raj Kumar et al. ENDOCRINE REVIEWS
- Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers
- (2011) S. Park et al. ANNALS OF ONCOLOGY
- Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy
- (2011) Sibylle Loibl et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
- (2011) Min Ni et al. CANCER CELL
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase II trial of exemestane in combination with fulvestrant in postmenopausal women with hormone responsive advanced breast cancer: no evidence of a pharmacokinetic interaction between exemestane and fulvestrant.
- (2010) E Mrozek et al. CANCER RESEARCH
- Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element
- (2010) M. Lanzino et al. NUCLEIC ACIDS RESEARCH
- Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells
- (2009) Francesca De Amicis et al. BREAST CANCER RESEARCH AND TREATMENT
- Mechanism of androgen receptor action
- (2009) Jin Li et al. MATURITAS
- Androgen-Responsive Gene Database: Integrated Knowledge on Androgen-Responsive Genes
- (2009) Mei Jiang et al. MOLECULAR ENDOCRINOLOGY
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
- Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory
- (2008) Zeina Nahleh Future Oncology
- Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1
- (2008) J. Zhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started